methionine has been researched along with Salivary Gland Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, NJ; Conner, MW; Davide, JP; deSolms, SJ; Giuliani, EA; Gomez, RP; Graham, SL; Hamilton, K; Kohl, NE; Omer, CA | 1 |
| Barrington, RE; Bearss, DJ; Conner, MW; Gibbs, JB; Hamilton, K; Hundley, JE; Koblan, KS; Koester, SK; Kohl, NE; Miller, PJ; Mosser, SD; O'Neill, TJ; Oliff, A; Omer, CA; Rands, E; Schaber, MD; Senderak, ET; Subler, MA; Troyer, DA; Windle, JJ | 1 |
2 other study(ies) available for methionine and Salivary Gland Neoplasms
| Article | Year |
|---|---|
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Genes, ras; Mammary Neoplasms, Experimental; Methionine; Mice; Mice, Transgenic; Salivary Gland Neoplasms; Transferases | 1995 |
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Cycle; Enzyme Inhibitors; Farnesyltranstransferase; Female; Genes, ras; Humans; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Methionine; Mice; Mice, Transgenic; Salivary Gland Neoplasms | 1998 |